Evidence map›Paper›PMID 29452288›Full record

ArticleExperimental gerontology2018

Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia.

Ted G Graber, Brandy L Rawls, Bing Tian, William J Durham, Camille R Brightwell, Allan R Brasier, Blake B Rasmussen, Christopher S Fry

Abstract read
In one paragraph

Article in Experimental gerontology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Reduced KThe Journal of physiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Measuring Exercise Capacity and Physical Function in Adult and Older Mice.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ted G GraberDivision of Rehabilitation Science, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States; Department of Nutrition and Metabolism, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: thgraber@utmb.edu.
Brandy L RawlsDepartment of Nutrition and Metabolism, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: blrawls@texaschildrens.org.
Bing TianDepartment of Internal Medicine, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States; Sealy Center for Molecular Medicine, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: bitian@utmb.edu.
William J DurhamDepartment of Internal Medicine, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: wjdurham@utmb.edu.
Camille R BrightwellProgram in Cell Biology, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: cabright@utmb.edu.
Allan R BrasierDepartment of Internal Medicine, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States; Sealy Center for Molecular Medicine, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: arbrasie@utmb.edu.
Blake B RasmussenDepartment of Nutrition and Metabolism, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: blrasmus@utmb.edu.
Christopher S FryDepartment of Nutrition and Metabolism, University of Texas Medical Branch, 301 University BLVD, Galveston, TX 77555, United States. Electronic address: csfry@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI GAROFALO, ROBERTO P · 2005 to 2022
$23.9M
Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Molecular Mechanisms of Environmental InjuryT32ES007254 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI AMEREDES, BILL T · 1990 to 2022
$6.6M
HEALTH OF OLDER MINORITIEST32AG000270 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Brian Gregory Downer, NEIL MEHTA · 1999 to 2026
$5.2M
UTMB Clinical and Translational Science AwardKL2TR001441 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI AMEREDES, BILL T · 2015 to 2024
$4.0M
UTMB Clinical and Translational Science AwardTL1TR001440 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HOMMEL, JONATHAN DEAN · 2015 to 2024
$3.4M
Nutrient Sensing & Signaling in Aging MuscleR56AG051267 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RASMUSSEN, BLAKE B · 2015 to 2015
$468k
NCATS NIH HHS KL2 TR001441NCATS NIH HHS TL1 TR001440NCATS NIH HHS UL1 TR001439NIAID NIH HHS P01 AI062885NIA NIH HHS P30 AG024832NIA NIH HHS R56 AG051267NIA NIH HHS T32 AG000270NIEHS NIH HHS P30 ES006676NIEHS NIH HHS T32 ES007254
6 · The paper itself

Abstract

Due to immunosenescence, older adults are particularly susceptible to lung-based viral infections, with increased severity of symptoms in those with underlying chronic lung disease. Repeated respiratory viral infections produce lung maladaptations, accelerating pulmonary dysfunction. Toll like 3 receptor (TLR3) is a membrane protein that senses exogenous double-stranded RNA to activate the innate immune response to a viral infection. Polyinosinic-polycytidylic acid [poly(I:C)] mimics double stranded RNA and has been shown to activate TLR3. Utilizing an established mouse viral exacerbation model produced by repetitive intranasal poly(I:C) administration, we sought to determine whether repetitive poly(I:C) treatment induced negative muscle adaptations (i.e. atrophy, weakness, and loss of function). We determined skeletal muscle morphological properties (e.g. fiber-type, fiber cross-sectional area, muscle wet mass, etc.) from a treated group ((poly(I:C), n = 9) and a sham-treated control group (PBS, n = 9); age approximately 5 months. In a subset (n = 4 for both groups), we determined in vivo physical function (using grip test for strength, rotarod for overall motor function, and treadmill for endurance) and muscle contractile properties with in vitro physiology (in the EDL, soleus and diaphragm). Our findings demonstrate that poly(I:C)-treated mice exhibit both muscle morphological and functional deficits. Changes of note when comparing poly(I:C)-treated mice to PBS-treated controls include reductions in fiber cross-sectional area (-27% gastrocnemius, -25% soleus, -16% diaphragm), contractile dysfunction (soleus peak tetanic force, -26%), muscle mass (gastrocnemius -19%, soleus -23%), physical function (grip test -34%), body mass (-20%), and altered oxidative capacity (140% increase in succinate dehydrogenase activity in the diaphragm, but 66% lower in the gastrocnemius). Our data is supportive of a new model of cachexia/sarcopenia that has potential for future research into the mechanisms underlying muscle wasting.

Indexed as

ImmunosenescenceAnimalsCachexiaDisease Models, AnimalExercise TestMaleMiceMice, Inbred C57BLMuscle ContractionMuscle, SkeletalMuscular AtrophyOrgan SizePoly I-CPulmonary Disease, Chronic ObstructiveSarcopeniaToll-Like Receptor 3Poly I-CTLR3 protein, mouseToll-Like Receptor 3AgeingCOPD cachexiaMouse modelsPhysical functionSkeletal muscleTLR3

Identifiers

PMID29452288
PMCPMC5911410
OpenAlexW2792312640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.